OBJECTIVE: Coronary microvascular dysfunction (CMD) is a predictor of cardiac death in diabetes mellitus (DM) independent of traditional cardiovascular (CV) risk factors. Rheumatoid arthritis (RA) is a chronic inflammatory condition, with excess CV risk compared to the general population, in which CMD is hypothesized to play a role; however, there are limited data on CMD in RA and any association with clinical outcomes. The objective of this study was to compare the prevalence of CMD in RA to that in DM and to test the association with all-cause mortality. METHODS: We performed a retrospective cohort study using data from a registry of all patients undergoing stress myocardial perfusion positron emission tomography as part of routine clinical care from 2006 to 2017. The inclusion criterion was a normal perfusion scan. Patients with RA or DM were classified using previously published approaches. Coronary flow reserve (CFR) was calculated for all patients in the registry and linked with mortality data. CMD was defined as CFR <2.0. RESULTS: We studied 73 patients with RA and 441 patients with DM. Among patients with a normal perfusion scan, the prevalence of CMD in RA was similar to that in DM (P = 0.2). CMD was associated with increased risk for all-cause mortality in RA (hazard ratio 2.4 [95% confidence interval 1.4-4.2]) as well as increased risk for cardiac-related death at rates similar to those in DM. CONCLUSION: These findings suggest an important role for CMD as a potential contributor to excess CV risk and mortality in RA, as previously observed in DM, as well as evidence for a mechanistic link between inflammation and cardiovascular disease.
OBJECTIVE: Coronary microvascular dysfunction (CMD) is a predictor of cardiac death in diabetes mellitus (DM) independent of traditional cardiovascular (CV) risk factors. Rheumatoid arthritis (RA) is a chronic inflammatory condition, with excess CV risk compared to the general population, in which CMD is hypothesized to play a role; however, there are limited data on CMD in RA and any association with clinical outcomes. The objective of this study was to compare the prevalence of CMD in RA to that in DM and to test the association with all-cause mortality. METHODS: We performed a retrospective cohort study using data from a registry of all patients undergoing stress myocardial perfusion positron emission tomography as part of routine clinical care from 2006 to 2017. The inclusion criterion was a normal perfusion scan. Patients with RA or DM were classified using previously published approaches. Coronary flow reserve (CFR) was calculated for all patients in the registry and linked with mortality data. CMD was defined as CFR <2.0. RESULTS: We studied 73 patients with RA and 441 patients with DM. Among patients with a normal perfusion scan, the prevalence of CMD in RA was similar to that in DM (P = 0.2). CMD was associated with increased risk for all-cause mortality in RA (hazard ratio 2.4 [95% confidence interval 1.4-4.2]) as well as increased risk for cardiac-related death at rates similar to those in DM. CONCLUSION: These findings suggest an important role for CMD as a potential contributor to excess CV risk and mortality in RA, as previously observed in DM, as well as evidence for a mechanistic link between inflammation and cardiovascular disease.
Authors: M Turiel; L Tomasoni; S Sitia; S Cicala; L Gianturco; C Ricci; F Atzeni; V De Gennaro Colonna; M Longhi; P Sarzi-Puttini Journal: Cardiovasc Ther Date: 2010-10 Impact factor: 3.023
Authors: Shawn Murphy; Susanne Churchill; Lynn Bry; Henry Chueh; Scott Weiss; Ross Lazarus; Qing Zeng; Anil Dubey; Vivian Gainer; Michael Mendis; John Glaser; Isaac Kohane Journal: Genome Res Date: 2009-07-14 Impact factor: 9.043
Authors: E E A Arts; C Popa; A A Den Broeder; A G Semb; T Toms; G D Kitas; P L van Riel; J Fransen Journal: Ann Rheum Dis Date: 2014-01-03 Impact factor: 19.103
Authors: Venkatesh L Murthy; Masanao Naya; Viviany R Taqueti; Courtney R Foster; Mariya Gaber; Jon Hainer; Sharmila Dorbala; Ron Blankstein; Ornella Rimoldi; Paolo G Camici; Marcelo F Di Carli Journal: Circulation Date: 2014-04-30 Impact factor: 29.690
Authors: Steven A J Chamuleau; Martijn Meuwissen; Karel T Koch; Berthe L F van Eck-Smit; Rene A Tio; Jan G P Tijssen; Jan J Piek Journal: Am J Cardiol Date: 2002-02-15 Impact factor: 2.778
Authors: Fabiola Atzeni; Piercarlo Sarzi-Puttini; Giuseppe De Blasio; Luigi Delfino; Livio Tomasoni; Maurizio Turiel Journal: Ann N Y Acad Sci Date: 2007-06 Impact factor: 5.691
Authors: Brittany Weber; Dana Weisenfeld; Thany Seyok; Sicong Huang; Elena Massarotti; Leanne Barrett; Courtney Bibbo; Daniel H Solomon; Jorge Plutzky; Marcy Bolster; Marcelo Di Carli; Katherine P Liao Journal: J Am Heart Assoc Date: 2022-06-03 Impact factor: 6.106
Authors: Brittany N Weber; Emma Stevens; Lourdes M Perez-Chada; Jenifer M Brown; Sanjay Divakaran; Camden Bay; Courtney Bibbo; Jon Hainer; Sharmila Dorbala; Ron Blankstein; Viviany R Taqueti; Joseph F Merola; Elena Massarotti; Karen Costenbader; Katherine Liao; Marcelo F Di Carli Journal: JACC Cardiovasc Imaging Date: 2021-03-17
Authors: Ashley S Manchanda; Alan C Kwan; Mariko Ishimori; Louise E J Thomson; Debiao Li; Daniel S Berman; C Noel Bairey Merz; Caroline Jefferies; Janet Wei Journal: Front Cardiovasc Med Date: 2022-04-15